A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Kura Oncology, Inc.
Kura Oncology, Inc.
Baylor College of Medicine
Fred Hutchinson Cancer Center
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Ipsen
Amgen
Novartis
Celgene
Acrotech Biopharma Inc.
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Centre Antoine Lacassagne
University of California, San Francisco